Browse By: Country ι Category ι Tag

Hepatitis Market Research Reports

Hepatitis C Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2014 - 2020
Hepatitis is defined as the inflammation of the liver due to an infection by a virus or other causative organism or toxin. Hepatitis C on the other hand, is primarily as a result of the infection by hepatitis C virus (HCV). With a cure rate between 50%-80%, and no commercially available vaccine as of yet, hepatitis C is considered a deadly disease with a moderate to high infection rate. It is the leading cause for liver transplantation in the U.K and North America.  The transmission of this virus in a majority occurs from injectables drug abuse, as the virus can only be transmitted via blood-to-blood contact. The secondary transmission factors include tattooing, sexual contact, healthcare (blood transfusion, organ transplant) mishaps, and other rare unknown cases. HIV infected indi
Published Date: Apr 2025
Published By: Transparency

Price: $5795
Hepatitis Diagnostic Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 - 2018
Hepatitis is a medical condition characterized by inflammation of the liver which often leads to other complications such as jaundice, anorexia, liver failure and cirrhosis. Hepatitis is generally of two types- acute when it lasts for less than six months and chronic when it lasts for longer period. It can be caused by a group of viruses called as hepatitis viruses which include groups A, B, C, D, and E. The most observed types of this disease are hepatitis A, hepatitis B and hepatitis C. Globally, 350 million people are chronically infected with any one form of hepatitis and around 500,000 people die every year according to World Health Organization. Hepatitis A is a simpler form of which does not lead to chronic infections. Patients suffering from hepatitis A recover within two mont
Published Date: Nov 2020
Published By: Transparency

Price: $5795
Alcoholic Hepatitis - Pipeline Review, H1 2017
Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Alcoholic Hepatitis - Pipeline Review, H1 2017, provides an overview of the Alcoholic Hepatitis (Gastrointestinal) pipeline landscape. Alcoholic hepatitis is an inflammation of the liver. It is typically caused by excessive alcohol consumption over a long period of time. Symptoms include changes in appetite, dry mouth, weight loss, yellowing of the skin or eyes (jaundice), fever and fatigue. Risk factors include alcohol use, obesity and genetic factors. Treatment includes corticosteroids and liver transplant. Report Highlights Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Alcoholic Hepatitis - Pipeline Review, H1 2017, provides comprehensive information on the th
Published Date: Apr 2017
Published By: Global Markets Direct

Price: $2000
United States Human Hepatitis B Immunoglobulin (IM) Market Report 2017
Geographically, this report splits the United States market into seven regions: The West Southwest The Middle Atlantic New England The South The Midwest with sales (volume), revenue (value), market share and growth rate of Human Hepatitis B Immunoglobulin (IM) in these regions, from 2012 to 2022 (forecast). United States Human Hepatitis B Immunoglobulin (IM) market competition by top manufacturers/players, with Human Hepatitis B Immunoglobulin (IM) sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including Baxter CSL Bayer Grifols Octapharma Shanghai RAAS Hualan Biological China Biologic Tiantan Biologic Shuanglin Bio-pharmacy Sichuan Yuanda Shuyang Boya Bio-p
Published Date: Apr 2017
Published By: QYResearch

Price: $3800
Global Hepatitis B Virus Core Antibody Diagnostic Kits Market Research Report 2017
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Hepatitis B Virus Core Antibody Diagnostic Kits in these regions, from 2012 to 2022 (forecast), covering North America Europe China Japan Southeast Asia India Global Hepatitis B Virus Core Antibody Diagnostic Kits market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including Shanghai Kehua Bio Livzon Pharmaceutical Group Weihai Weigao Biotechnology Rongsheng Wantai Biophram Asintec Acon Shenzhen Kang Sheng Bao Bio-Technology Autobio Beijing Kewei Clinical Diagnostic Peagents Henan Lili Bi
Published Date: Apr 2017
Published By: QYResearch

Price: $2900
EMEA (Europe, Middle East and Africa) Human Hepatitis B Immunoglobulin (HBIG) Market Report 2017
Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Human Hepatitis B Immunoglobulin (HBIG) for these regions, from 2012 to 2022 (forecast) Europe: Germany, France, UK, Russia, Italy and Benelux; Middle East: Saudi Arabia, Israel, UAE and Iran; Africa: South Africa, Nigeria, Egypt and Algeria. EMEA Human Hepatitis B Immunoglobulin (HBIG) market competition by top manufacturers/players, with Human Hepatitis B Immunoglobulin (HBIG) sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including Baxter CSL Bayer Grifols Octapharma Shanghai RAAS Hualan Biological China Bio
Published Date: Apr 2017
Published By: QYResearch

Price: $4000
Global Human Hepatitis B Immunoglobulin (IM) Sales Market Report 2017
Geographically, this report split global into several key Regions, with sales (MT), revenue (Million USD), market share and growth rate of Human Hepatitis B Immunoglobulin (IM) for these regions, from 2012 to 2022 (forecast), covering United States China Europe Japan Southeast Asia India Global Human Hepatitis B Immunoglobulin (IM) market competition by top manufacturers/players, with Human Hepatitis B Immunoglobulin (IM) sales volume, Price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including Baxter CSL Bayer Grifols Octapharma Shanghai RAAS Hualan Biological China Biologic Tiantan Biologic Shuanglin Bio-pharmacy Sichuan Yuanda Shuyang Boya Bio-pharmaceutical
Published Date: Mar 2017
Published By: QYResearch

Price: $4000
Global Human Hepatitis B Immunoglobulin (IM) Market Research Report 2017
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Human Hepatitis B Immunoglobulin (IM) in these regions, from 2012 to 2022 (forecast), covering North America Europe China Japan Southeast Asia India Global Human Hepatitis B Immunoglobulin (IM) market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including Baxter CSL Bayer Grifols Octapharma Shanghai RAAS Hualan Biological China Biologic Tiantan Biologic Shuanglin Bio-pharmacy Sichuan Yuanda Shuyang Boya Bio-pharmaceutical Shanghai Institute of Biological On the basis of product, t
Published Date: Mar 2017
Published By: QYResearch

Price: $2900
Global Human Hepatitis B Immunoglobulin (IM)Market Research Report 2017
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Human Hepatitis B Immunoglobulin (IM)in these regions, from 2012 to 2022 (forecast), covering North America Europe China Japan Southeast Asia India Global Human Hepatitis B Immunoglobulin (IM)market competition by top manufacturers, with production, price, revenue (value)and market share for each manufacturer; the top players including Baxter CSL Bayer Grifols Octapharma Shanghai RAAS Hualan Biological China Biologic Tiantan Biologic Shuanglin Bio-pharmacy Sichuan Yuanda Shuyang Boya Bio-pharmaceutical Shanghai Institute of Biological On the basis of product, this
Published Date: Mar 2017
Published By: QYResearch

Price: $2900
United States Human Hepatitis B Immunoglobulin (HBIG) Market Report 2017
Geographically, this report splits the United States market into seven regions: The West Southwest The Middle Atlantic New England The South The Midwest with sales (volume), revenue (value), market share and growth rate of Human Hepatitis B Immunoglobulin (HBIG) in these regions, from 2012 to 2022 (forecast). United States Human Hepatitis B Immunoglobulin (HBIG) market competition by top manufacturers/players, with Human Hepatitis B Immunoglobulin (HBIG) sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including Baxter CSL Bayer Grifols Octapharma Shanghai RAAS Hualan Biological China Biologic Tiantan Biologic Shuanglin Bio-pharmacy Sichuan Yuanda Shuyang Boya
Published Date: Mar 2017
Published By: QYResearch

Price: $3800
China Nonalcoholic Steatohepatitis (NASH) Market Research Report 2017
Sales, means the sales volume of Nonalcoholic Steatohepatitis (NASH) Revenue, means the sales value of Nonalcoholic Steatohepatitis (NASH) This report studies Nonalcoholic Steatohepatitis (NASH) in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering Boehringer Ingelheim? Cerenis Therapeutics? Connexios Life Sciences? Genfit? Islet Sciences? Nimbus Therapeutics? Verva Pharmaceuticals? Viking Therapeutics? Astazeneca Plc Galmed Pharmaceuticals Ltd. GENFIT SA Gilead Science Novo Nordisk Immuron Ltd Intercepts Pharmaceuticals Enzo Biochem, Inc Tobira Therapeutics, Inc. Market Segment by Regions (provinces), covering South Ch
Published Date: Mar 2017
Published By: QYResearch

Price: $3200
Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Report 2017
Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Human Hepatitis B Immunoglobulin (HBIG) for these regions, from 2012 to 2022 (forecast), covering United States China Europe Japan Southeast Asia India Global Human Hepatitis B Immunoglobulin (HBIG) market competition by top manufacturers/players, with Human Hepatitis B Immunoglobulin (HBIG) sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including Baxter CSL Bayer Grifols Octapharma Shanghai RAAS Hualan Biological China Biologic Tiantan Biologic Shuanglin Bio-pharmacy Sichuan Yuanda Shuyang Boya Bio-pharma
Published Date: Mar 2017
Published By: QYResearch

Price: $4000
United States Hepatitis A Vaccine Market Report 2017
Geographically, this report splits the United States market into seven regions, The West, Southwest, The Middle Atlantic, New England, The South and The Midwest, with sales (volume), revenue (value), market share and growth rate of Hepatitis A Vaccine in these regions, from 2012 to 2022 (forecast). The major players in United States market include Sanofi Pasteur, Crucell, GlaxoSmithKline, Sinovac Biotech, Merck & Co., Pukang Biotec, Aventis Pasteur India Ltd, Janssen Pharmaceutical Companies. On the basis of product, the Hepatitis A Vaccine market is primarily split into Only for Hepatitis A, Combination Vaccine etc. with sales, revenue, price, market share and growth rate of each type, On the basis on the end users/applications, this report covers Clinics and Hospital, Public Service, an
Published Date: Mar 2017
Published By: QYResearch

Price: $3855
China Hepatitis Vaccine Market Research Report 2017
Sales, means the sales volume of Hepatitis Vaccine Revenue, means the sales value of Hepatitis Vaccine This report studies Hepatitis Vaccine in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering GlaxoSmithKline Sanofi Pasteur Merck Novartis Pfizer Seqirus Protein Sciences ... Market Segment by Regions (provinces), covering South China East China Southwest China Northeast China North China Central China Northwest China Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into Type I Type II Split by Application, this report focuses on consumption, market share and
Published Date: Mar 2017
Published By: QYResearch

Price: $3200
Global Hepatitis A Vaccine Industry Situation and Prospects Research report
The Global Hepatitis A Vaccine Industry Situation and Prospects Research report is a professional and in-depth study on the current state of the Hepatitis A Vaccine industry. In 2016, the world economy expanded by just 2.2 per cent, the slowest rate of growth since the Great Recession of 2009. Underpinning the sluggish global economy are the feeble pace of global investment, dwindling world trade growth, flagging productivity growth and high levels of debt. World gross product is forecast to expand by 2.7 per cent in 2017 and 2.9 per cent in 2018, with this modest recovery more an indication of economic stabilization than a signal of a robust and sustained revival of global demand. Given the close linkages between demand, investment, trade and productivity, the extended episode of weak
Published Date: Mar 2017
Published By: Stanley Consulting Company (SCC)

Price: $2850
Global Human Hepatitis B Immunoglobulin (HBIG) Market Research Report 2017
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Human Hepatitis B Immunoglobulin (HBIG) in these regions, from 2012 to 2022 (forecast), covering North America Europe China Japan Southeast Asia India Global Human Hepatitis B Immunoglobulin (HBIG) market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including Baxter CSL Bayer Grifols Octapharma Shanghai RAAS Hualan Biological China Biologic Tiantan Biologic Shuanglin Bio-pharmacy Sichuan Yuanda Shuyang Boya Bio-pharmaceutical Shanghai Institute of Biological On the basis of produc
Published Date: Mar 2017
Published By: QYResearch

Price: $2900
Europe Nonalcoholic Steatohepatitis (NASH) Market Report 2017
Sales, means the sales volume of Nonalcoholic Steatohepatitis (NASH) Revenue, means the sales value of Nonalcoholic Steatohepatitis (NASH) This report studies sales (consumption) of Nonalcoholic Steatohepatitis (NASH) in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering Boehringer Ingelheim? Cerenis Therapeutics? Connexios Life Sciences? Genfit? Islet Sciences? Nimbus Therapeutics? Verva Pharmaceuticals? Viking Therapeutics? Astazeneca Plc Galmed Pharmaceuticals Ltd. GENFIT SA Gilead Science Novo Nordisk Immuron Ltd Intercepts Pharmaceuticals Enzo Biochem, Inc
Published Date: Mar 2017
Published By: QYResearch

Price: $3900
Europe Hepatitis Vaccine Market Report 2017
Sales, means the sales volume of Hepatitis Vaccine Revenue, means the sales value of Hepatitis Vaccine This report studies sales (consumption) of Hepatitis Vaccine in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering GlaxoSmithKline Sanofi Pasteur Merck Novartis Pfizer Seqirus Protein Sciences ... Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Hepatitis Vaccine in these countries, from 2011 to 2021 (forecast), like Germany France UK Russia Italy Spain Benelux Spl
Published Date: Mar 2017
Published By: QYResearch

Price: $3900
United States Nonalcoholic Steatohepatitis (NASH) Market Report 2017
Sales, means the sales volume of Nonalcoholic Steatohepatitis (NASH) Revenue, means the sales value of Nonalcoholic Steatohepatitis (NASH) This report studies sales (consumption) of Nonalcoholic Steatohepatitis (NASH) in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering Boehringer Ingelheim? Cerenis Therapeutics? Connexios Life Sciences? Genfit? Islet Sciences? Nimbus Therapeutics? Verva Pharmaceuticals? Viking Therapeutics? Astazeneca Plc Galmed Pharmaceuticals Ltd. GENFIT SA Gilead Science Novo Nordisk Immuron Ltd Intercepts Pharmaceuticals Enzo Biochem, Inc Tobira Therapeutics, Inc. Market Segment by States, covering California Texas Ne
Published Date: Mar 2017
Published By: QYResearch

Price: $3800
Non-Alcoholic Steatohepatitis - Pipeline Review, H1 2017
Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Non-Alcoholic Steatohepatitis – Pipeline Review, H1 2017, provides an overview of the Non-Alcoholic Steatohepatitis (Gastrointestinal) pipeline landscape. Non-alcoholic steatohepatitis (NASH) is liver inflammation caused by a buildup of fat in the liver. NASH can get worse and cause scarring of the liver, which leads to cirrhosis. Symptoms of NASH include fatigue, weight loss for no clear reason, general weakness and an ache in the upper right part of belly. Risk factors include obesity, type 2 diabetes, high cholesterol and high triglycerides and metabolic syndrome. Report Highlights Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Non-Alcoholic Steatohepatitis
Published Date: Feb 2017
Published By: Global Markets Direct

Price: $2000

Upcoming Reports

Wheelchair Accessible Vehicle Converters Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
Vehicles which are converted in a way that have easy access for wheelchairs are termed as wheelchair accessible vehicles or WAV’s. The vehicles are specially converted from a standard vehicle to WAV in order to accommodate the wheelchair. Wheelchair accessible vehicles are considered as mult
Published By: Transparency
Price: $5795
Enteral Nutrition Pumps Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
Enteral nutrition pumps also known as enteral feeding pumps are used to deliver nutritious foods containing carbohydrate, protein, fat, vitamin, minerals and water by inserting directly into the stomach or parts of small intestine. Enteral nutrition pumps are recommended to patients suffering from
Published By: Transparency
Price: $5795
Residential Water Treatment Equipment Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2014 - 2020
Increasing industrial and environmental pollution around the world is increasing the need for water treatment. Water pollution due to increasing industrialization and environment pollution is leading to death and spread of diseases. It also adversely affects more than 1 billion of population every
Published By: Transparency
Price: $5795
Steam Boiler System Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth and Forecast 2014 - 2020
The growing need of effective heating systems as well as the requirement of increasing operating efficiency of residential and commercial complexes has led to the widespread adoption of steam boiler systems. This technology provides high steam temperature and improved pressure parameters to achiev
Published By: Transparency
Price: $5795
Seismic Survey Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth and Forecast 2014 - 2020
Increasing exploration activities owing to the efforts of oil and gas companies to locate new oil and gas reserves is expected to drive the global seismic survey market during the forecast period. Oil and gas companies use seismic surveys to map and interpret potential petroleum reserves.  P
Published By: Transparency
Price: $5795

Back To Top